Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Sequent Scientific

Sector: Healthcare | Industry: Drugs & Pharma
R 74.85 -2.70  | -3.48% 44.78% 32.51 1,847.83
NSE Price: Oct 15, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:59 74.85 -2.70 -3.48% 77.00 77.55 165,058 74.50 - 77.50
BSE Oct 15, 2019 74.85 -2.60 -3.36% 76.20 77.45 19,019 74.25 - 77.35
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 429,034 P/B: 2.63 NSE Code: SEQUENT
52-Week Range: R 44.50 - 89.40 Dividend Yield: 0.27% BSE Code: 512529
TTM EPS: R 2.30 Book Value: R 28.48 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Our equity analyst team has sifted through hundreds of companies and selected a short list of stocks that you should invest in.
This list now has 38 stocks on it. Thousands of our members are using stagnant equity markets to buy great stocks at low prices.

Membership is currently available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Sequent Scientific 10.89 -10.73 11.72 45.20 -16.47 -3.05 19.65
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 0.85 18.47 17.94
Net Profit -86.80 76.20 20.25
EPS -88.60 65.62 17.49
Book Value 7.79 -10.36 69.83
Average
Operating Margin 12.86 10.96 10.16
Net Margin 5.43 14.73 7.83
Return on Networth 8.63 20.35 5.92
Return on Investment 9.28 17.14 12.22
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -1.38 18.23 -1.38
Operating Profit -4.04 63.39 -4.04
Net Profit -28.28 241.43 -28.28
EPS -33.09 249.26 -33.09
TTM
Revenue 4.12 21.54 4.12
Operating Profit 11.54 41.67 11.54
Net Profit 19.02 -84.37 19.02
EPS 16.80 -86.55 16.80
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Sequent Scientific 1,847.83 1,082.17 67.69 6.21 8.63 2.63 32.51
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Dec 05, 2018 Padmakumar Karunakaran Pillai  Sell Market 45,000 70.80 31.86
Oct 10, 2018 Rajitha Gopalakrishnan  Buy Market 25,000 44.75 11.19
Oct 09, 2018 Sajitha Pillai  Buy Market 35,833 42.65 15.28
Oct 01, 2018 Chayadeep Properties Pvt Ltd  Buy Market 200,000 49.25 98.50
Jul 20, 2018 SAJITHA PILLAI Revised  Buy Market 39,167 50.20 19.66
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
SBI Mutual Fund 3.817 3.866 3.866 4.070 4.529
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Sequent Scientific Ltd.

Address: 301, 'dosti Pinnacle', 3rd Floor, Plot No. E7, Road No. 22, Wagle Indl. Estate, Thane (W), Thane, Maharashtra - 400604

Email: [email protected]

Website: http://www.sequent.in/

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

Essential checks
Altman Z-Score
3.49
Piotroski F-Score
7
Modified C-Score
1
5-Years Price to Earnings
32.51
5-Years Price to Book
2.63
Earnings Yield
EBIT / Enterprise value
5.00%
PEG
Price / Earnings to growth ratio
1.55
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59